Answers are grounded in this paper and cite their sources.
Efficacy and safety findings from two pivotal Phase 3 studies of lasmiditan for acute treatment of migraine are reported here.
No takes yet. Share an insight, caveat, or question.
Wietecha et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: